Valeant (VRX) options active after U.S. probe into potential defrauding of insurers

Valeant Pharma (NYSE: VRX) is recently down $2.51 to $24.80 after U.S. probe into potential defrauding of insurers. August weekly call option implied volatility is at 88, August is at 67, September is at 64; compared to its 52-week range of 34 to 175.

You May Also Be Interested In

• Cadence Design Systems (CDNS) option implied volatility into quarter results
• Super Micro Computer (SMCI) call put ratio 1.2 calls to 1 put as share price down 10.3%
• TripAdvisor (TRIP) options active on volume of 12K contracts